Researchers interviewed 169 practicing gastroenterologists and 22 academic experts to determine the treatment recommended and the treatment actually given. Differences were found in the use of IgA anti-endomysial antibodies, human leukocyte antigen DQ2/8 testing, gluten challenge and oat consumption.
Academic experts more frequently recommended CD screening for patients with type 1 diabetes and Down and Turner syndromes, as well as for relatives of CD patients.
Related Articles on Celiac Disease:
Celiac Cases Rising, Cause Unknown
Mayo Clinic Gastroenterologist Details Role of Endoscopic Imaging in Small Bowel
Texas Gastroenterologist Featured for Use of Capsule Endoscopy
